Suchergebnisse - "Cappello, Maria"

PubPharm (162)

61

Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)

enthalten in: Drugs & aging | 2020

von Porcari, S. | Viola, A. | Orlando, A. | +21

62

Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)

enthalten in: Drugs & aging | 2020

von Porcari, S. | Viola, A. | Orlando, A. | +21

63

Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy : How to maintain standards of care

enthalten in: United European Gastroenterology Journal | 2020

von Saibeni, S. | Scucchi, L. | Dragoni, G. | +43

64

Effectiveness and safety of vedolizumab in biologically naïve patients : A real‐world multi‐centre study

enthalten in: United European Gastroenterology Journal | 2020

von Macaluso, F. | Fries, W. | Renna, S. | +16

65

Late-onset Crohn's disease : a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study

enthalten in: European journal of gastroenterology & hepatology | 2019

von Viola, A. | Monterubbianesi, R. | Scalisi, G. | +33

66

Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis

enthalten in: Digestive diseases and sciences | 2019

von Bossa, F. | Biscaglia, G. | Valvano, M. | +32

67

Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis

enthalten in: Digestive diseases and sciences | 2019

von Bossa, F. | Biscaglia, G. | Valvano, M. | +32

68

Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis

enthalten in: Digestive diseases and sciences | 2019

von Bossa, F. | Biscaglia, G. | Valvano, M. | +32

69

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

enthalten in: The New England journal of medicine | 2019

von Sands, B. | Peyrin-Biroulet, L. | Loftus, E. | +111

CommentIn: N Engl J Med. 2019 Sep 26;381(13):1279-1281. - PMID 31553842

70

Inflammatory Bowel Disease Onset During Secukinumab Treatment : Real Concern or Just an Expression of Dysregulated Immune Response?

enthalten in: Clinical drug investigation | 2019

von Fries, W. | Belvedere, A. | Cappello, M. | +2